Form 4: Director Gary Ellis Receives RSU Grant at Inspire Medical

Director Gary Lee Ellis was granted 3,562 restricted stock units by Inspire Medical Systems, Inc. on April 30, 2026.

Summary

• Director Gary Lee Ellis acquired 3,562 restricted stock units (RSUs) of Inspire Medical Systems, Inc. (INSP).
• The transaction occurred on April 30, 2026, at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership of common stock increased to 10,838 shares.
• The RSUs represent a contingent right to receive one share of common stock per unit.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to the director's continued service with the issuer.
• The value of the equity is subject to market volatility of INSP common stock.

Future Outlook

The RSUs are scheduled to vest on the first anniversary of the grant date (April 30, 2027) or immediately prior to a Change of Control, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder interests in the medical device sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for mid-cap medical technology companies.
• The vesting schedule of one year is typical for director equity awards in the healthcare industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation award.

Next Steps

• Vesting of the 3,562 RSUs on April 30, 2027, or upon a potential Change of Control.

Key Dates

Keywords

Inspire Medical Systems, INSP, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction